SPY336.83-0.61 -0.18%
DIA279.42-0.62 -0.22%
IXIC11,042.50+30.27 0.27%

Fennec Pharmaceuticals Q3 EPS $(0.09) Up From $(0.14) YoY

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.09) per share. This is a 35.71 percent increase over losses of $(0.14) per share from the same period last year.

Benzinga · -

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.09) per share. This is a 35.71 percent increase over losses of $(0.14) per share from the same period last year.